首页> 外国专利> Clinical applications of formulations containing adipose-derived stem cells

Clinical applications of formulations containing adipose-derived stem cells

机译:含有脂肪干细胞的制剂的临床应用

摘要

Methods and kits for producing cellular fractions enriched in adipose derived stem cells. Methods are provided where adipose tissue obtained from liposuction is enzymatically treated using a solution containing collagenase and divalent cations prior to the application of traditional methods of stromal-vascular fraction isolation. The enzymatic solutions may contain collagenase types I and II to a final concentration of about 0.001 mg/ml to 0.010 mg/ml. The divalent cations may be present as calcium, magnesium, and zinc chloride. The final concentration of calcium, magnesium, and zinc may range from about 0.001 to 0.1 micromolar; about 0.005 to 0.5 micromolar; and about 0.0015 to 0.15 micromolar, respectively. The enzymatic solutions may be generated using a kit where the collagenase and divalent components are held in separate containers until just prior to use. The cellular fractions isolated in this manner may be used in autologous fat grafts in therapeutic applications.
机译:用于生产富含脂肪干细胞的细胞级分的方法和试剂盒。提供了以下方法,其中在应用传统的间质-血管部分分离方法之前,使用包含胶原酶和二价阳离子的溶液对通过抽脂获得的脂肪组织进行酶处理。所述酶溶液可以包含I型和II型胶原酶,其最终浓度为约0.001mg / ml至0.010mg / ml。二价阳离子可以钙,镁和氯化锌的形式存在。钙,镁和锌的最终浓度可以在约0.001至0.1微摩尔之间;约0.005至0.5微摩尔;分别为约0.0015至0.15微摩尔。可以使用试剂盒产生酶溶液,其中将胶原酶和二价成分保存在单独的容器中直至使用前。以这种方式分离的细胞级分可以用于治疗应用中的自体脂肪移植物中。

著录项

  • 公开/公告号US9956317B2

    专利类型

  • 公开/公告日2018-05-01

    原文格式PDF

  • 申请/专利权人 ANTRIA INC.;

    申请/专利号US201615131441

  • 发明设计人 SHAHRAM RAHIMIAN;

    申请日2016-04-18

  • 分类号C12N9/00;C12N5/071;A61L27/38;A61K35/35;A61L27/36;A61L15/44;A61L15/40;A61L27/54;C12N5/0775;

  • 国家 US

  • 入库时间 2022-08-21 12:57:10

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号